Resistance against apoptosis by the cellular prion protein is dependent on its glycosylation status in oral HSC-2 and colon LS 174T cancer cells

Cancer Letters

Volumn 306, Issue 1, 2011, Pages 111-119

  Yap, Yeannie Hui Yeng ^a   Say, Yee How ^a  

^a UNIVERSITI TUNKU ABDUL RAHMAN   (Malaysia)

Author keywords

Cancer; Cellular prion protein; N linked glycosylation; Oxidative stress; Tunicamycin

Indexed keywords

PRION PROTEIN; SHORT HAIRPIN RNA; TUNICAMYCIN;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CANCER RESISTANCE; CARCINOMA CELL; COLON ADENOCARCINOMA; CONTROLLED STUDY; DRUG INHIBITION; GENE FUNCTION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC STABILITY; MOUTH CARCINOMA; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; SQUAMOUS CELL CARCINOMA;

ANTI-BACTERIAL AGENTS; ANTIOXIDANTS; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; COLONIC NEOPLASMS; ENDOPLASMIC RETICULUM; GLYCOSYLATION; HELA CELLS; HUMANS; MITOCHONDRIA; MOUTH NEOPLASMS; OXIDATIVE STRESS; PRIONS; REACTIVE OXYGEN SPECIES; TETRAZOLIUM SALTS; THIAZOLES; TIME FACTORS; TUNICAMYCIN;

EID: 79955465845     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.02.040     Document Type: Article

References (28)

1. Prusiner S.B. Prions. Proc. Natl. Acad. Sci. USA 1998, 95:13363-13383.
2. Caughey B., Kocisko D.A., Raymond G.J., Lansbury P.T. Aggregates of scrapie-associated prion protein induce the cell-free conversion of protease-sensitive prion protein to the protease-resistant state. Chem. Biol. 1995, 2:807-817.
3. A Harris D. Cellular biology of prion diseases. Clin. Microbiol. Rev. 1999, 12:429-444.
4. Lehmann S., Milhavet O., Mangé A. Trafficking of the cellular isoform of the prion protein. Biomed. Pharmacother. 1999, 53:39-46.
5. C Joao H., Dwek R.A. Effects of glycosylation on protein structure and dynamics in ribonuclease B and some of its individual glycoforms. Eur. J. Biochem. 1993, 218:239-244.
6. Taraboulos A., Rogers M., Borchelt D.R., McKinley M.P., Scott M., Serban D., Prusiner S.B. Acquisition of protease resistance by prion proteins in scrapie-infected cells does not require asparagine-linked glycosylation. Proc. Natl. Acad. Sci. USA 1990, 87:8262-8266.
7. Korth C., Kaneko K., Prusiner S.B. Expression of unglycosylated mutated prion protein facilitates PrP(Sc) formation in neuroblastoma cells infected with different prion strains. J. Gen. Virol. 2000, 81:2555-2563.
8. Lehmann S., Harris D.A. Blockade of glycosylation promotes acquisition of scrapie-like properties by the prion protein in cultured cells. J. Biol. Chem. 1997, 272:21479-21487.
9. Lawson V.A., Collins S.J., Masters C.L., Hill A.F. Prion protein glycosylation. J. Neurochem. 2005, 93:793-801.
10. Dricu A., Carlberg M., Wang M., Larsson O. Inhibition of N-linked glycosylation using tunicamycin causes cell death in malignant cells: role of down-regulation of the insulin-like growth factor 1 receptor in induction of apoptosis. Cancer Res. 1997, 57:543-548.
11. Carlberg M., Dricu A., Blegen H., Kass G.E.N., Orrenius S., Larsson O. Short exposures to tunicamycin induce apoptosis in SV40-transformed but not in normal human fibroblasts. Carcinogenesis 1996, 17:2589-2596.
12. Yang Y., Chen L., Pan H.Z., Kou Y., Xu C.M. Glycosylation modification of human prion protein provokes apoptosis in HeLa cells in vitro. BMB Rep. 2009, 42:331-337.
13. Yuan B., Latek R., Hossbach M., Tuschl T., Lewitter F. siRNA selection server: an automated siRNA oligonucleotide prediction server. Nucl. Acids. Res. 2004, 32:W130-W134.
14. Moffat J., Grueneberg D.A., Yang X., Kim S.Y., Kloepfer A.M., Hinkle G., Piqani B., Eisenhaure T.M., Luo B., Grenier J.K., Carpenter A.E., Foo S.Y., Stewart S.A., Stockwell B.R., Hacohen N., Hahn W.C., Lander E.S., Sabatini D.M., Root D.E. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 2006, 124:1283-1298.
15. Mehrpour M., Codogno P. Prion protein: From physiology to cancer biology. Cancer Lett. 2010, 290:1-23.
16. Mangé A., Béranger F., Peoc'h K., Onodera T., Frobert Y., Lehmann S. Alpha- and beta-cleavages of the amino-terminus of the cellular prion protein. Biol. Cell 2004, 96:125-132.
17. McMahon H.E., Mangé A., Nishida N., Créminon C., Casanova D., Lehmann S. Cleavage of the amino terminus of the prion protein by reactive oxygen species. J. Biol. Chem. 2001, 276:2286-2291.
18. Watt N.T., Taylor D.R., Gillott A., Thomas D.A., Perera W.S., Hooper N.M. Reactive oxygen species-mediated beta-cleavage of the prion protein in the cellular response to oxidative stress. J. Biol. Chem. 2005, 280:35914-35921.
19. Hsieh Y.H., Su I.J., Lei H.Y., Lai M.D., Chang W.W., Huang W. Differential endoplasmic reticulum stress signaling pathways mediated by iNOS. Biochem. Biophys. Res. Commun. 2007, 359:643-648.
20. Lewis V., Collins S.J. Analysis of endogenous PrPC processing in neuronal and non-neuronal cell lines. Methods Mol. Biol. 2008, 459:229-239.
21. Orsi A., Fioriti L., Chiesa R., Sitia R. Conditions of endoplasmic reticulum stress favor the accumulation of cytosolic prion protein. J. Biol. Chem. 2006, 281:30431-30438.
22. Malhotra J.D., Kaufman R.J. Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword?f. Antioxid. Redox Signal. 2007, 9:2277-2293.
23. Malhotra J.D., Miao H., Zhang K., Wolfson A., Pennathur S., Pipe S.W., et al. Antioxidants reduce endoplasmic reticulum stress and improve protein secretion. Proc. Natl. Acad. Sci. USA 2008, 105:18525-18530.
24. Chen L., Yang Y., Han J., Zhang B.Y., Zhao L., Nie K., Wang X.F., Li F., Gao C., Dong X.P., Xu C.M. Removal of the glycosylation of prion protein provokes apoptosis in SF126. J. Biochem. Mol. Biol. 2007, 40:662-669.
25. Noda I., Fujieda S., Seki M., Tanaka N., Sunaga H., Ohtsubo T., Tsuzuki H., Fan G.-K., Saito H. Inhibition of N-linked glycosylation by tunicamycin enhances sensitivity to cisplatin in human head-and-neck carcinoma cells. Int. J. Cancer 1999, 80:279-284.
26. Hiss D.C., Gabriels G.A., Folb P.I. Combination of tunicamycin with anticancer drugs synergistically enhances their toxicity in multidrug-resistant human ovarian cystadenocarcinoma cells. Cancer Cell Int. 2007, 7:5.
27. Li Q.Q., Cao X.X., Xu J.D., Chen Q., Wang W.J., Tang F., Chen Z.Q., Liu X.P., Xu Z.D. The role of P-glycoprotein/cellular prion protein interaction in multidrug-resistant breast cancer cells treated with paclitaxel. Cell Mol. Life Sci. 2009, 66:504-515.
28. Du J., Pan Y., Shi Y., Guo C., Jin X., Sun L., Liu N., Qiao T., Fan D. Overexpression and significance of prion protein in gastric cancer and multidrug-resistant gastric carcinoma cell line SGC7901/ADR. Int. J. Cancer 2005, 113:213-220.